.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
UBS
Deloitte
Harvard Business School
Colorcon
Daiichi Sankyo
Accenture
Farmers Insurance
Chubb
Julphar

Generated: December 12, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078337

« Back to Dashboard

NDA 078337 describes BETAMETHASONE VALERATE, which is a drug marketed by Perrigo Uk Finco, Riconpharma Llc, Taro Pharm, Fougera Pharms Inc, Perrigo New York, Pharmaderm, Pharmafair, Taro, Sti Pharma Llc, Teva Pharms, and Actavis Mid Atlantic, and is included in eighteen NDAs. It is available from fifteen suppliers. Additional details are available on the BETAMETHASONE VALERATE profile page.

The generic ingredient in BETAMETHASONE VALERATE is betamethasone valerate. There are sixty-six drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.

Summary for 078337

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Adrenal)
Formulation / Manufacturing:see details

Pharmacology for NDA: 078337

Medical Subject Heading (MeSH) Categories for 078337

Suppliers and Packaging for NDA: 078337

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BETAMETHASONE VALERATE betamethasone valerate AEROSOL, FOAM;TOPICAL 078337 ANDA Perrigo New York Inc 45802-053 45802-053-01 1 CAN in 1 CARTON (45802-053-01) > 50 g in 1 CAN
BETAMETHASONE VALERATE betamethasone valerate AEROSOL, FOAM;TOPICAL 078337 ANDA Perrigo New York Inc 45802-053 45802-053-02 1 CAN in 1 CARTON (45802-053-02) > 100 g in 1 CAN

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:AEROSOL, FOAM;TOPICALStrength0.12%
Approval Date:Nov 26, 2012TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Accenture
Covington
Fish and Richardson
McKesson
Healthtrust
Chinese Patent Office
Deloitte
Julphar
UBS
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot